Canopy Growth (CGC) Cash from Investing Activities (QoQ) (2019 - 2024)
Canopy Growth (CGC) Cash from Investing Activities (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Canopy Growth | 276.52 Mn | 10.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 39.32% |
| Sep 30, 2024 | 94.84% |
| Jun 30, 2024 | -343.24% |
| Mar 31, 2024 | 2,992.38% |
| Dec 31, 2023 | -101.00% |
| Sep 30, 2023 | -57.73% |
| Jun 30, 2023 | 57.24% |
| Mar 31, 2023 | -32.19% |
| Dec 31, 2022 | -60.47% |
| Sep 30, 2022 | 364.42% |
| Jun 30, 2022 | -139.95% |
| Mar 31, 2022 | 1,311.25% |
| Dec 31, 2021 | -107.55% |
| Sep 30, 2021 | 185.58% |
| Jun 30, 2021 | 30.53% |
| Mar 31, 2021 | -339.06% |
| Dec 31, 2020 | 272.02% |
| Sep 30, 2020 | 65.28% |
| Jun 30, 2020 | -522.13% |
| Mar 31, 2020 | -109.97% |